Encorafenib

All ESMO 2014 abstracts with reference to encorafenib are listed below

• 535P - Encorafenib (LGX818), an oral BRAF inhibitor, in patients (pts) with BRAF V600E metastatic colorectal cancer (mCRC): Results of dose expansion in an open-label, phase 1 study